Compare OPBK & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | OPBK | PMI |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.7M | 202.7M |
| IPO Year | 2018 | N/A |
| Metric | OPBK | PMI |
|---|---|---|
| Price | $13.23 | $1.01 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 31.9K | ★ 181.0K |
| Earning Date | 04-23-2026 | 04-01-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | ★ 23.74 | N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $3,204,000.00 | N/A |
| Revenue This Year | $16.07 | N/A |
| Revenue Next Year | $11.60 | N/A |
| P/E Ratio | $7.25 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.43 | $0.96 |
| 52 Week High | $15.27 | $13.68 |
| Indicator | OPBK | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 34.93 |
| Support Level | $12.74 | N/A |
| Resistance Level | $13.24 | $1.37 |
| Average True Range (ATR) | 0.40 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 55.09 | 4.28 |
OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.